These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 16534223)

  • 1. Influence of different lipid-lowering strategies on plaque volume and plaque composition in patients with coronary artery disease: role of intravascular ultrasound imaging.
    Bocksch W; Fateh-Moghadam S; Huehns S; Schartl M
    Kidney Blood Press Res; 2005; 28(5-6):290-4. PubMed ID: 16534223
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Early statin treatment in patients with acute coronary syndrome: demonstration of the beneficial effect on atherosclerotic lesions by serial volumetric intravascular ultrasound analysis during half a year after coronary event: the ESTABLISH Study.
    Okazaki S; Yokoyama T; Miyauchi K; Shimada K; Kurata T; Sato H; Daida H
    Circulation; 2004 Aug; 110(9):1061-8. PubMed ID: 15326073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of combined lipid lowering and blood pressure control on coronary plaque: myocardial ischemia treated by percutaneous coronary intervention and plaque regression by lipid lowering and blood pressure controlling assessed by intravascular ultrasonography (MILLION) study.
    Kawashiri MA; Sakata K; Hayashi K; Gamou T; Kanaya H; Miwa K; Ueda K; Higashikata T; Mizuno S; Michishita I; Namura M; Nitta Y; Katsuda S; Okeie K; Hirase H; Tada H; Uchiyama K; Konno T; Ino H; Nagase K; Yamagishi M;
    Heart Vessels; 2017 May; 32(5):539-548. PubMed ID: 27798731
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serial intravascular ultrasound assessment of changes in coronary atherosclerotic plaque dimensions and composition: an update.
    Hartmann M; Huisman J; Böse D; Jensen LO; Schoenhagen P; Mintz GS; Erbel R; von Birgelen C
    Eur J Echocardiogr; 2011 Apr; 12(4):313-21. PubMed ID: 21421584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Determinants of arterial wall remodeling during lipid-lowering therapy: serial intravascular ultrasound observations from the Reversal of Atherosclerosis with Aggressive Lipid Lowering Therapy (REVERSAL) trial.
    Schoenhagen P; Tuzcu EM; Apperson-Hansen C; Wang C; Wolski K; Lin S; Sipahi I; Nicholls SJ; Magyar WA; Loyd A; Churchill T; Crowe T; Nissen SE
    Circulation; 2006 Jun; 113(24):2826-34. PubMed ID: 16769916
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HMG-CoA reductase inhibitor (Statin) therapy and coronary atherosclerosis in Japanese subjects: role of high-density lipoprotein cholesterol.
    Tani S; Nagao K; Hirayama A
    Am J Cardiovasc Drugs; 2011 Dec; 11(6):411-7. PubMed ID: 22149320
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Goal of Achieving Atherosclerotic Plaque Regression with Lipid-Lowering Therapy: Insights from IVUS Trials.
    Daida H; Dohi T; Fukushima Y; Ohmura H; Miyauchi K
    J Atheroscler Thromb; 2019 Jul; 26(7):592-600. PubMed ID: 31118346
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of obesity on lipid-lowering, anti-inflammatory, and antiatherosclerotic benefits of atorvastatin or pravastatin in patients with coronary artery disease (from the REVERSAL Study).
    Nicholls SJ; Tuzcu EM; Sipahi I; Schoenhagen P; Hazen SL; Ntanios F; Wun CC; Nissen SE
    Am J Cardiol; 2006 Jun; 97(11):1553-7. PubMed ID: 16728212
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Usefulness of follow-up low-density lipoprotein cholesterol level as an independent predictor of changes of coronary atherosclerotic plaque size as determined by intravascular ultrasound analysis after statin (atorvastatin or simvastatin) therapy.
    Hong MK; Lee CW; Kim YH; Park DW; Lee SW; Park CB; Jang JS; Han KH; Cheong SS; Kim JJ; Park SW; Park SJ
    Am J Cardiol; 2006 Oct; 98(7):866-70. PubMed ID: 16996864
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plaque stabilization by intensive LDL-cholesterol lowering therapy with atorvastatin is delayed in type 2 diabetic patients with coronary artery disease-Serial angioscopic and intravascular ultrasound analysis.
    Takayama T; Hiro T; Ueda Y; Honye J; Komatsu S; Yamaguchi O; Li Y; Yajima J; Takazawa K; Nanto S; Saito S; Hirayama A; Kodama K
    J Cardiol; 2013 Jun; 61(6):381-6. PubMed ID: 23478121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Achieving optimal lipid goals in patients with coronary artery disease.
    Karalis DG; Subramanya RD; Hessen SE; Liu L; Victor MF
    Am J Cardiol; 2011 Mar; 107(6):886-90. PubMed ID: 21247526
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting low HDL-cholesterol to decrease residual cardiovascular risk in the managed care setting.
    Cziraky MJ; Watson KE; Talbert RL
    J Manag Care Pharm; 2008 Oct; 14(8 Suppl):S3-28; quiz S30-1. PubMed ID: 19891279
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serial intravascular ultrasound evidence of both plaque stabilization and lesion progression in patients with ruptured coronary plaques: effects of statin therapy on ruptured coronary plaque.
    Hong MK; Mintz GS; Lee CW; Suh IW; Hwang ES; Jeong YH; Park DW; Kim YH; Han KH; Cheong SS; Kim JJ; Park SW; Park SJ
    Atherosclerosis; 2007 Mar; 191(1):107-14. PubMed ID: 16584733
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Regression of a large lipid-rich pool in the coronary artery during treatment with statin detected by intravascular ultrasound: a case report].
    Takashima H; Yasukawa T; Ozaki Y; Asai K; Shinjo H; Waseda K; Kuroda Y; Wakita Y; Kosaka T; Kuhara Y; Ito T
    J Cardiol; 2006 Jun; 47(6):307-12. PubMed ID: 16800374
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HDL-C: role as a risk modifier.
    Barter P
    Atheroscler Suppl; 2011 Nov; 12(3):267-70. PubMed ID: 22152280
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Assessment of progression and regression of coronary atherosclerosis by intravascular ultrasound. A new paradigm shift?].
    Nicholls SJ; Sipahi I; Tuzcu EM
    Rev Esp Cardiol; 2006 Jan; 59(1):57-66. PubMed ID: 16434005
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intravascular ultrasound for the evaluation of therapies targeting coronary atherosclerosis.
    Böse D; von Birgelen C; Erbel R
    J Am Coll Cardiol; 2007 Mar; 49(9):925-32. PubMed ID: 17336714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of imaging end points in atherosclerosis trials: focus on intravascular ultrasound.
    Kalidindi SR; Tuzcu EM; Nicholls SJ
    Int J Clin Pract; 2007 Jun; 61(6):951-62. PubMed ID: 17504358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atherosclerotic plaque reduction: blood pressure, dyslipidemia, atherothrombosis.
    Arora S; Nicholls SJ
    Drugs Today (Barc); 2008 Sep; 44(9):711-8. PubMed ID: 19137125
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statins, high-density lipoprotein cholesterol, and regression of coronary atherosclerosis.
    Nicholls SJ; Tuzcu EM; Sipahi I; Grasso AW; Schoenhagen P; Hu T; Wolski K; Crowe T; Desai MY; Hazen SL; Kapadia SR; Nissen SE
    JAMA; 2007 Feb; 297(5):499-508. PubMed ID: 17284700
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.